Liposome News and Research

Latest Liposome News and Research

Liposomes not capable of transporting themselves deep into the skin

Liposomes not capable of transporting themselves deep into the skin

New drug delivery system can reduce size of ovarian tumors by as much as 83%

New drug delivery system can reduce size of ovarian tumors by as much as 83%

Gilead Sciences fourth quarter total revenues increase 18% to $2.59 billion

Gilead Sciences fourth quarter total revenues increase 18% to $2.59 billion

Sun Pharma receives FDA approval for generic Doxil

Sun Pharma receives FDA approval for generic Doxil

Celsion's ThermoDox does not meet primary endpoint in Phase III HCC study

Celsion's ThermoDox does not meet primary endpoint in Phase III HCC study

New method allows controlled release of drugs; could help develop targeted treatments

New method allows controlled release of drugs; could help develop targeted treatments

Iclusig gets FDA approval for two rare blood and bone marrow diseases

Iclusig gets FDA approval for two rare blood and bone marrow diseases

Bio-Path to initiate BP-100-1.01 Phase I trial for treatment of two types of breast cancer

Bio-Path to initiate BP-100-1.01 Phase I trial for treatment of two types of breast cancer

ALN RNAi therapeutic program represents novel approach for treatment of AAT deficiency

ALN RNAi therapeutic program represents novel approach for treatment of AAT deficiency

New gene delivery vehicle opens route to the heart of cells in solid tumors

New gene delivery vehicle opens route to the heart of cells in solid tumors

Azaya Therapeutics commences ATI-0918 bioequivalence study in ovarian cancer

Azaya Therapeutics commences ATI-0918 bioequivalence study in ovarian cancer

FDA approved drug to treat Ph- acute lymphoblastic leukemia

FDA approved drug to treat Ph- acute lymphoblastic leukemia

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

Bio-Path initiates enrollment in fourth cohort of Liposomal Grb-2 Phase I trial for blood cancers

Bio-Path initiates enrollment in fourth cohort of Liposomal Grb-2 Phase I trial for blood cancers

Johnson & Johnson second quarter sales decrease 0.7% to $16.5B

Johnson & Johnson second quarter sales decrease 0.7% to $16.5B

Azaya announces final results from ATI-1123 Phase I study on cancers

Azaya announces final results from ATI-1123 Phase I study on cancers

Nanocontainers can fight against atherosclerosis

Nanocontainers can fight against atherosclerosis

Pacira first quarter total revenues increase to $7.8 million

Pacira first quarter total revenues increase to $7.8 million

Pacira secures $27.5 million debt financing facility

Pacira secures $27.5 million debt financing facility

Magnetic nanochain detonates chemo barrage inside tumors

Magnetic nanochain detonates chemo barrage inside tumors